Abstract

In the title compound, C13H12ClN5, which is a derivative of the anti­tumor agent pazopanib {systematic name: 5-[[4-[(2,3-di­methyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methylbenzolsulfonamide}, the indazole and pyrim­idine fragments form a dihedral angle of 62.63 (5)°. In the crystal, pairs of mol­ecules related by twofold rotational symmetry are linked into dimers through π–π inter­actions between the indazole ring systems [centroid–centroid distance = 3.720 (2) Å]. Weak inter­molecular C—H⋯N hydrogen bonds further assemble these dimers into columns propagated in [001].

Highlights

  • C13H12ClN5, which is a derivative of the antitumor agent pazopanib {systematic name: 5-[[4-[(2,3dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methylbenzolsulfonamide}, the indazole and pyrimidine fragments form a dihedral angle of 62.63 (5)

  • Pairs of molecules related by twofold rotational symmetry are linked into dimers through – interactions between the indazole ring systems [centroid–centroid distance = 3.720 (2) A ]

  • R-factors based on F2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger

Read more

Summary

Structure Reports Online

Key indicators: single-crystal X-ray study; T = 113 K; mean (C–C) = 0.002 A; R factor = 0.036; wR factor = 0.100; data-to-parameter ratio = 13.3. C13H12ClN5, which is a derivative of the antitumor agent pazopanib {systematic name: 5-[[4-[(2,3dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methylbenzolsulfonamide}, the indazole and pyrimidine fragments form a dihedral angle of 62.63 (5). Pairs of molecules related by twofold rotational symmetry are linked into dimers through – interactions between the indazole ring systems [centroid–centroid distance = 3.720 (2) A ]. Weak intermolecular C—HÁ Á ÁN hydrogen bonds further assemble these dimers into columns propagated in [001]. Related literature For background to the pharmacokinetics and clinical studies of the antitumor agent pazopanib, see: Limvorasak & Posadas (2009); Sloan & Scheinfeld 2008; Sonpavde et al (2007).

Data collection
HÁ Á ÁA
Crystal data
Special details
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.